Koortslipcrème

Aciclovir, the active ingredient in Koortslipcrème, is an antiviral presented as a cream for topical use. It treats herpes simplex virus infections—including cold sores, genital herpes and shingles—by delivering the medication directly to the affected skin area in patients who need localized therapy.

GNH USA supplies Koortslipcrème as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare facilities worldwide, ensuring consistent quality and regulatory compliance across global markets through reliable logistics and dedicated customer support and timely delivery.

Aciclovir is an antiviral agent used to manage infections caused by the herpes simplex virus family.

Herpes labialis (cold sores): Reduces lesion duration and promotes faster healing when applied at the first sign of symptoms. Genital herpes: Helps to alleviate outbreak severity and shorten healing time with regular topical application. Herpes zoster (shingles): Provides localized antiviral activity to lessen skin lesion development and discomfort when used as directed.

Topical application of Koortslipcrème may cause local skin reactions, although many patients experience no adverse events.

Common Side Effects: - Mild burning or stinging at the application site - Redness or erythema around the treated area - Itching or mild pruritus - Dryness or flaking of the skin - Slight swelling or edema

Serious or Rare Side Effects: - Allergic contact dermatitis with rash and blistering - Severe skin irritation or ulceration - Systemic hypersensitivity reactions such as urticaria - Unexpected worsening of lesions - Rare anaphylactic response requiring immediate medical attention

Before using Koortslipcrème, consider the following safety measures.

Avoid use on extensive damaged skin: Limit application to intact or mildly affected areas. Do not apply to eyes or mucous membranes: Prevent irritation by keeping the product away from these sites. Discontinue if severe irritation occurs: Seek medical advice if reactions worsen. Consult a healthcare professional for pediatric use: Dosing and safety in children should be assessed by a clinician. Store at below 25°C: Keep in the original tube, protect from moisture and direct sunlight.

Koortslipcrème has limited systemic absorption, but certain co‑administered agents may influence its safety profile.

Major Interactions (Avoid): - Concurrent use of other topical antivirals: May increase risk of local skin irritation. - Systemic immunosuppressants: Could diminish overall antiviral effectiveness.

Moderate Interactions (Monitor Closely): - Systemic aciclovir or valacyclovir: Potential additive antiviral activity. - Topical corticosteroids: May mask local irritation signs. - Heavy moisturizers containing alcohol: Could alter cream absorption.